-
1 Comment
Aytu BioScience, Inc is currently in a long term downtrend where the price is trading 93.6% below its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.1.
Aytu BioScience, Inc's total revenue rose by 839.0% to $14M since the same quarter in the previous year.
Its net income has increased by 12.6% to $-4M since the same quarter in the previous year.
Finally, its free cash flow fell by 166.9% to $-8M since the same quarter in the previous year.
Based on the above factors, Aytu BioScience, Inc gets an overall score of 3/5.
Exchange | F |
---|---|
CurrencyCode | EUR |
ISIN | None |
Sector | Healthcare |
Industry | Biotechnology |
Target Price | None |
---|---|
Market Cap | 7M |
PE Ratio | None |
Beta | 0.2 |
Dividend Yield | None |
Aytu BioScience, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company markets Natesto, a nasal gel for the treatment of hypogonadism (low testosterone) in men; and Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension. It also offers ZolpiMist, an oral spray for the treatment of insomnia; and MiOXSYS, an in vitro diagnostic semen analysis test that is used in the measurement of static oxidation reduction potential in human semen. Aytu BioScience, Inc. is based in Englewood, Colorado.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for AY21.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025